Sign in

CIK 0001789972

  • Non-accelerated filer
  • Smaller reporting company

Cullinan Therapeutics, Inc.

Sign in to watch
Ticker
CGEM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813879991
Phone
+1 617-410-4650
Business address
ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
Former names
Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$222,000
in 2 filings, $222K under 10b5-1 plans

Net −$222,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Michaelson Jennifer −$222K Chief Scientific Officer sold 7% of stake
Date Insider Transaction Shares Price Value Owned after
2026-02-24 AHMED NADIM President and CEO Sale −13,515 $14.47 $196K 390,803
2026-02-20 AHMED NADIM President and CEO Sale −16,381 $13.62 $223K 404,318
2026-02-18 AHMED NADIM President and CEO Grant or award · Stock Option (Right to Buy) +828,000 828,000
2025-12-23 AHMED NADIM President and CEO Sale −9,922 $10.01 $99K 420,699
2025-02-25 AHMED NADIM President and CEO Sale −12,529 $8.53 $107K 430,621
2025-02-19 AHMED NADIM President and CEO Grant or award +180,000 443,150
2025-02-19 AHMED NADIM President and CEO Grant or award · Stock Option (Right to Buy) +360,000 360,000
2024-12-24 AHMED NADIM President and CEO Sale −8,400 $11.87 $100K 263,150
2024-02-22 AHMED NADIM President and CEO Grant or award +160,000 271,550
2024-02-22 AHMED NADIM President and CEO Grant or award · Stock Option (Right to Buy) +320,000 320,000
2023-12-26 AHMED NADIM President and CEO Sale −4,272 $9.24 $39K 111,550
2023-06-28 AHMED NADIM President and CEO Sale −759 $11.40 $9K 115,822
2023-05-23 AHMED NADIM President and CEO Sale −707 $9.15 $6K 116,581
2023-04-25 AHMED NADIM President and CEO Sale −716 $10.59 $8K 117,288
2023-03-23 AHMED NADIM President and CEO Sale −706 $10.51 $7K 118,004
2023-02-22 AHMED NADIM President and CEO Grant or award +109,000 118,710
2023-02-22 AHMED NADIM President and CEO Grant or award · Stock Option (Right to Buy) +211,000 211,000
2022-06-30 AHMED NADIM President and CEO Grant or award +1,620 $10.90 $18K 9,710
2022-06-06 AHMED NADIM President and CEO Purchase +8,090 $12.40 $100K 8,090
2022-03-05 AHMED NADIM President and CEO Grant or award · Performance Stock Unit +215,000 215,000

Page 1 of 2 · 21 trades